BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12886175)

  • 1. Comparing the cost-effectiveness of the triple test score to traditional methods for evaluating palpable breast masses.
    Morris AM; Flowers CR; Morris KT; Schmidt WA; Pommier RF; Vetto JT
    Med Care; 2003 Aug; 41(8):962-71. PubMed ID: 12886175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of the triple test score for palpable breast masses; discussion 1012-3.
    Morris KT; Pommier RF; Morris A; Schmidt WA; Beagle G; Alexander PW; Toth-Fejel S; Schmidt J; Vetto JT
    Arch Surg; 2001 Sep; 136(9):1008-12. PubMed ID: 11529822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accurate evaluation of palpable breast masses by the triple test score.
    Morris A; Pommier RF; Schmidt WA; Shih RL; Alexander PW; Vetto JT
    Arch Surg; 1998 Sep; 133(9):930-4. PubMed ID: 9749842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A modified triple test for palpable breast masses: the value of ultrasound and core needle biopsy.
    Wai CJ; Al-Mubarak G; Homer MJ; Goldkamp A; Samenfeld-Specht M; Lee Y; Logvinenko T; Rothschild JG; Graham RA
    Ann Surg Oncol; 2013 Mar; 20(3):850-5. PubMed ID: 23104707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costs and effects of ultrasonography in the evaluation of palpable breast masses.
    Flobbe K; Kessels AG; Severens JL; Beets GL; de Koning HJ; von Meyenfeld MF; van Engelshoven JM
    Int J Technol Assess Health Care; 2004; 20(4):440-8. PubMed ID: 15609793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of abnormal mammography results and palpable breast abnormalities.
    Kerlikowske K; Smith-Bindman R; Ljung BM; Grady D
    Ann Intern Med; 2003 Aug; 139(4):274-84. PubMed ID: 12965983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined fine-needle aspiration, physical examination and mammography in the diagnosis of palpable breast masses: their relation to outcome for women with primary breast cancer.
    Steinberg JL; Trudeau ME; Ryder DE; Fishell E; Chapman JA; McCready DR; Fish EB; Hiraki GY; Ross TM; Lickley LA
    Can J Surg; 1996 Aug; 39(4):302-11. PubMed ID: 8697321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of palpable breast lesions in younger women by the modified triple test is accurate and cost-effective.
    Vetto JT; Pommier RF; Schmidt WA; Eppich H; Alexander PW
    Arch Surg; 1996 Sep; 131(9):967-72; discussion 972-4. PubMed ID: 8790167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Follow-up of palpable circumscribed noncalcified solid breast masses at mammography and US: can biopsy be averted?
    Graf O; Helbich TH; Fuchsjaeger MH; Hopf G; Morgun M; Graf C; Mallek R; Sickles EA
    Radiology; 2004 Dec; 233(3):850-6. PubMed ID: 15486217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a clinical decision rule for triage of women with palpable breast masses.
    Reeves MJ; Osuch JR; Pathak DR
    J Clin Epidemiol; 2003 Jul; 56(7):636-45. PubMed ID: 12921932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of fine-needle aspiration in the evaluation of persistent palpable dominant breast masses.
    Hindle WH; Payne PA; Pan EY
    Am J Obstet Gynecol; 1993 Jun; 168(6 Pt 1):1814-8; discussion 1818-9. PubMed ID: 8317526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of fine needle aspiration for solid breast lesions is accurate and cost-effective.
    Rubin M; Horiuchi K; Joy N; Haun W; Read R; Ratzer E; Fenoglio M
    Am J Surg; 1997 Dec; 174(6):694-6; discussion 697-8. PubMed ID: 9409599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The palpable breast nodule. A cost-effectiveness analysis of alternate diagnostic approaches.
    Layfield LJ; Chrischilles EA; Cohen MB; Bottles K
    Cancer; 1993 Sep; 72(5):1642-51. PubMed ID: 8348496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of inconclusive breast FNA by triple test.
    Mansoor I; Zahrani I
    J Pak Med Assoc; 2002 Jan; 52(1):25-9. PubMed ID: 11963581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The value of aspiration cytology within the scope of triple diagnosis of palpable breast changes].
    Schuhmann R; Hübner F; Brose C; Eckel S; Geier G; Kraus H; Schöndorf H; Schöndorf NK
    Geburtshilfe Frauenheilkd; 1995 Oct; 55(10):553-8. PubMed ID: 8543127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fine-needle aspiration cytology for diagnosis and management of palpable breast mass.
    Kanchanabat B; Kanchanapitak P; Thanapongsathorn W; Manomaiphiboon A
    Aust N Z J Surg; 2000 Nov; 70(11):791-4. PubMed ID: 11147439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effective use of breast biopsy techniques in a Veterans health care system.
    Hatmaker AR; Donahue RM; Tarpley JL; Pearson AS
    Am J Surg; 2006 Nov; 192(5):e37-41. PubMed ID: 17071179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance goals for an adjunct diagnostic test to reduce unnecessary biopsies after screening mammography: analysis of costs, benefits, and consequences.
    Lee CI; Bensink ME; Berry K; Musa Z; Bodnar C; Dann R; Jarvik JG; Lehman CD; Ramsey SD
    J Am Coll Radiol; 2013 Dec; 10(12):924-30. PubMed ID: 24295942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of the "triple test" for palpable breast lesions yields high diagnostic accuracy and cost savings.
    Vetto J; Pommier R; Schmidt W; Wachtel M; DuBois P; Jones M; Thurmond A
    Am J Surg; 1995 May; 169(5):519-22. PubMed ID: 7747833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triple approach in the diagnosis of dominant breast masses: combined physical examination, mammography, and fine-needle aspiration.
    Kaufman Z; Shpitz B; Shapiro M; Rona R; Lew S; Dinbar A
    J Surg Oncol; 1994 Aug; 56(4):254-7. PubMed ID: 8057655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.